Article

MEEI has new laser to treat diabetic retinopathy

The Massachusetts Eye and Ear Infirmary (MEEI) acquired the newest laser for treating diabetic retinopathy.

Boston-The Massachusetts Eye and Ear Infirmary (MEEI) acquired the newest laser for treating diabetic retinopathy. The pattern scan laser photocoagulator (Pascal, OptiMedica) places an array of lower energy pulses across the retina, allowing patients to receive treatment in a single session as opposed to multiple sessions.

Also, the treatment results in less inflammation and blurring of vision after treatment.

"{MEEI's] acquisition of the laser, in combination with current technologies available at the hospital, including the retinal angiograph [Spectralis, Heidelberg] and optical coherence tomography (OCT), and spectral domain OCT [Carl Zeiss Meditec], make MEEI state of the art for retina diagnosis and treatment," said Joan W. Miller, MD, MEEI chief of ophthalmology and chairwoman of ophthalmology at Harvard Medical School. "Having the best tools helps our doctors give the very best care for patients."

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Deb Ristvedt, DO, on medications, lasers, and lifestyle in glaucoma management
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
At the Association for Research in Vision and Ophthalmology (ARVO) meeting, Katherine Talcott, MD, a retina specialist at Cleveland Clinic, shared her findings on EYP-1901 (EyePoint Pharmaceuticals) in the phase 2 DAVIO study.
Dr. Jogin Desai, founder of Eyestem Research, discusses his research at the Association for Research in Vision and Ophthalmology.
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
John Tan talks about an emergency triage framework for retinal artery occlusion at the 2025 Association for Research in Vision and Ophthalmology (ARVO) meeting.
Dr Robert Maloney at the 2025 Controversies in Modern Eye Care meeting
© 2025 MJH Life Sciences

All rights reserved.